On the other hand, a substantial stability was observed in 88% (22/25) of patients with myelofibrosis while the increase in JAK2 expression in three of 44 patients (6.8%) did not correspond to disease progression [37]. The gene discussed is JAK2; the disease is myelofibrosis.